Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Gross Profit 2022–2025
Indivior Pharmaceuticals, Inc. annual/quarterly gross profit history and growth rate from 2022 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Indivior Pharmaceuticals, Inc. gross profit for the quarter ending March 31, 2026 was 277.0 M, a 25.34% increase year-over-year.
- Indivior Pharmaceuticals, Inc. gross profit for the twelve months ending March 31, 2026 was 978.0 M.
- Indivior Pharmaceuticals, Inc. annual gross profit for 2025 was 994.0 M, a 3.87% increase from 2024.
- Indivior Pharmaceuticals, Inc. annual gross profit for 2024 was 957.0 M, a 4.13% increase from 2023.
- Indivior Pharmaceuticals, Inc. annual gross profit for 2023 was 919.0 M, a 22.70% increase from 2022.
- Indivior Pharmaceuticals, Inc. annual gross profit for 2022 was 749.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Indivior Pharmaceuticals, Inc. Gross Profit — FAQ
Indivior Pharmaceuticals, Inc. (INDV) gross profit over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Indivior Pharmaceuticals, Inc.'s gross profit?
Indivior Pharmaceuticals, Inc. (INDV) reported gross profit of $994M for fiscal 2025.
Where can I see INDV's gross profit history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s gross profit by year and by quarter, including the growth rate.